Literature DB >> 23056128

Review of High Level Endodontic Research in PubMed Index Journals from Iran.

Mohammad Jafar Eghbal1, Hassan Torabzadeh.   

Abstract

INTRODUCTION: This study aimed to evaluate patents as well as high level researches including systematic reviews/meta-analyses and randomized controlled clinical trials (RCT) published in scientific journals by Iranians endodontic.
MATERIALS AND METHODS: The study started with targeted searches of PubMed as well as World Intellectual Property Organization and United State Patent and Trademark Office.
RESULTS: There were 4 filed/granted patents, 2 systematic reviews/meta-analyses and 25 RCTs. Patents were related to endodontic/dental (bio)materials. Performing a topic sorting, 15 RCTs were about vital pulp therapy and 8 about anesthesia and pain. More than 55% of these articles originated from three University of Medical Sciences: Shahid Beheshti (22.2%), Kerman (18.5%) and Mashad (14.8%).
CONCLUSION: Vital pulp therapy was the most important topic amongst endodontic high level evidence articles.

Entities:  

Keywords:  Biomedical Research; Endodontics; Evidence-Based Dentistry; Iran; PubMed; Publications

Year:  2012        PMID: 23056128      PMCID: PMC3467136     

Source DB:  PubMed          Journal:  Iran Endod J        ISSN: 1735-7497


Introduction

Evidence-based practice aims to apply the best available evidence gained from scientific methods to clinical decision making. It appraises the strength of evidence of the risks/benefits of treatments as well as diagnostic tests. Evidence-based dentistry (EBD), as a subcategory, is an approach to oral health-care that needs a careful amalgamation of clinically relevant scientific evidence, relating to the patient’s oral condition/history, with the clinician’s skill as well as the patient’s treatment needs/preferences. EBD is about providing personalized dental care based on the current best evidence. The highest level of evidence available represents the current best evidence for a specific clinical question [1] Evidence levels follow a structured hierarchy of criteria for grading the strength of evidence. Some include assessment of a study’s methodological quality, precision of statistical data for the population being studied and other considerations. Although there is no single, universally-accepted hierarchy of evidence, there is broad agreement on the relative strength of the principal types of research. Systematic reviews, meta-analyses and randomized clinical trials rank top while case reports and expert opinions are ranked at the bottom [2][3]. The Oxford Centre for Evidence-based Medicine suggests level A of evidence (LOE1) for Randomized Controlled Clinical Trial (RCT) [4]. RCT is defined as a clinical study in which participants are randomly assigned to either an experimental group or control group. The experimental group receives the new intervention and the control group receives a placebo or standard intervention. These groups are followed for the outcomes of interest [1]. Scientometrics has been employed broadly for assessing the progress of science/technology. It uses articles and patents as important tools to map the development. A recent quantitative scientometric study showed that endodontic publications from different universities in Iran have considerably increased in PubMed index journals [5]. In addition, Iran was in the second rank in the region in year 2010 and the quantitative positive trend in published endodontic articles is considered as a sign of future success in acquiring Iran’s vision by 2025 [6]. However, a science system report from Iran shows some important qualitative weak points such as low expected levels of citations for Life sciences [7]. On the other hand, patent scientometrics is an approach to evaluate the development status of different technology fields. By counting the number of patents (filed or granted), the position of research productivity could be established [8]. In this study, we aimed to evaluate systematic reviews and RCTs as the highest level of evidence which were published in PubMed index journals by Iranian authors as well as patent counting in the field of endodontics.

Materials and Methods

MESH words searching method without time limitation was utilized for identifying PubMed-indexed endodontic articles [5]. Abstracts were reviewed based on the study design, and unrelated articles were excluded. The data of each article including the first author name/affiliation/publication year/journal name, topic/subject of article, sample size, study period, tested material or technique, and treatment outcomes were extracted. The World Intellectual Property Organization (WIPO) were searched as the main international and United State Patent and Trademark Office (USPTO) as the most important national agency were searched for Iranian inventors who filed or granted the patents.

Results

There was only one patent in WIPO, whereas 1 filed and 2 granted patents in USPTO (Table 1). Two systematic reviews about “smear layer” and “root resorption” were found in PubMed index journals (Table 2). The greatest portion of high level evidences (n=25) was related to RCTs (Table 3). Table 4 shows the topics of 25 RCTs. In respect to affiliation grouping, majority of publications belonged to Shahid Beheshti (22.2%),Kerman (18.5%) and Mashad (14.8%) Universities of Medical Sciences (Table 5).
Table 1

Four patents in WIPO and USPTO from Iranian endodontists

InventorTitleDate of applicationDate of publicationDate of approvalSovereign stateNumber
Asgary S and Ghassemian Pour Bavandi MEndodontic filling materialFebruary 22, 200728 August 200817 June 2012WIPOWO/2008/102214
Asgary SEndodontic filling materialJuly 16, 2007August 28, 2008May 17, 2011United States7,942,961 (Patent)
Asgary SMedical and dental biomaterial and method of use for the sameApril 1, 2011July 28, 2011January 31, 2012United States8,105,086 (Patent)
Saghiri MA et al.Dental cement compositionAugust 17, 2011January 19, 2012-United States20120012030
Table 2

Systematic reviews by Iranian endodontists

Author(s) Year Journal [Ref]TopicResults
Shahravan et al. (2007) JOE [9]Smear layersmear layer removal improves the seal
Ahangari et al. (2010) CDSR [10]External root resorptionLack of high level evidence
Table 3

The 25 randomized clinical trials by Iranian endodontists

Author(s)/Year/Journal/[Ref.]TopicSample sizeTimeMaterial(s)/ TechniqueTreatment Outcome
Asgary et al.(2012) COI [11]Pulpotomy (permanent molars)4076 and 12 monthCEM Cement vs. RCTCEM pulpotomy>RCT
Asgary and Eghbal (2012) AOS [12]Pulpotomy (permanent molars)4137 day and 12 monthCEM Cement vs. MTACEM Cement = MTA
Nosrat et al.(2012) IJPD [13]Pulpotomy (immature molars)11812 monthCEM Cement vs. MTACEM Cement = MTA
Eskandarizadeh et al.(2011) JCD [14]Pulp capping (permanent premolars)901, 2 and 3 monthWMTA Vs. GMTA vs. DycalWMTA = GMTA> Dycal
Zarrabi et al.(2011) JOE [15]Pulp capping (permanent premolars)322 and 8- weekCEM Cement vs. MTACEM Cement = MTA
Malekafzali et al.(2011) EJPD [16]Pulpotomy (primary molars)806, 12 and 24 monthCEM Cement vs. MTACEM Cement = MTA
Shahravan et al.(2011) IEJ [17]Pulp capping (third molars)2930 dayWMTA (various L/P ratios)no differences
Zarrabi et al.(2010) JOE [18]Pulp capping (permanent premolars)322 and 8 weekCEM Cement vs. MTACEM Cement = MTA
Ravanshad et al.(2010) JOE [19]Working length measurement188NAapex locator vs. radiographno differences
Aminabadi et al.(2010) JCPD [20]Pulp capping (primary molars)1202 yearFormocresol vs.CHFormocresol > CH
Parirokh et al.(2010) JOE [21]Anesthesia15015 minIbuprofen Vs. Indomethacin vs. PlaceboIbuprofen= Indomethacin> Placebo
Asgary and Eghbal (2010) Odont [22]Pulpotomy/Pain (permanent molars)4077-dayCEM Cement vs. RCTCEM pulpotomy>RCT
Ansari and Ranjpour (2010) IEJ [23]Pulpotomy (primary molars)401-, 6, 12 and 24 monthFormocresol vs. MTAFormocresol = MTA
Jalalzadeh et al.(2010) JOE [24]Postendodontic Pain406, 12, and 24 hoursPrednisolone Vs. placeboPrednisolone> placebo
Parirokh et al.(2010) OOO [25]Anesthesia84During access cavity preparationLidocaine Block vs. Block+Infiltration1Block+ 1Infiltration>1Block
Moghadamnia et al.(2009) IJDR [26]Anesthesia560,1, 3, 5, 7, 9 minAmitriptyline vs. PlaceboAmitriptyline > Placebo
Bahrololoomi et al.(2008) HJDR [27]Pulpotomy (primary molars)706 and 9 monthElectrosurgery vs.. FormocresolElectrosurgery = Formocre
Aminabadi et al.(2008) JCPD [28]Pulpotomy (primary incisors)10012 and 24 monthPulpotomy vs. RCTRCT > Pulpotomy
Noorollahian (2008) BDJ [29]Pulpotomy (primary molars)606, 12 and 24 monthFormocresol vs. MTAFormocresol = MTA
Mehrvarzfar et al.(2008) AEJ [30]Postendodontic Pain1006, 12, 24 and 48 hDexamethasone vs. PlaceboDexamethasone > Placebo
Aeinehchi et al.(2007) IEJ [31]Pulpotomy (primary molars)1263 and 6 monthFormocresol vs. MTAMTA> Formocresol
Ghoddusi et al.(2006) NYSDJ [32]Postendodontic Pain6072 hours1-visit Vs. 2-visit vs. 2-visit/CH
Modaresi et al.(2006) OOO [33]Anesthesia601 hourAcetaminophen vs. Ibuprofen vs. PlaceboIbuprofen> Acetaminophen> Placebo
Mortazavi and Mesbahi (2004) IJPD [34]RCT (primary teeth)523 and 10 16 monthVitapex vs. ZOEVitapex > ZOE
Sadeghein et al. (1999) JOE [35]Pain relief6690 minKetorolac vs.AcetaminophenKetorolac>Acetaminophen
Table 4

Number of different subjects in RCTs

SubjectNumber
Vital pulp therapy15
Anesthesia and pain8
Systematic Review2
Others2
Total27
Table 5

Number of articles from Iranian Universities

Medical University Number
Shahid Beheshti 6
Kerman 5
Mashad 4
Azad 2
Shiraz 2
Tabriz 2
Babol 1
Hamedan 1
Rafsanjan 1
Tehran 1
Yazd 1
Zahedan 1
Total 27

Discussion

Systematic Review is the gold standard for evidence; it provides a summary of individual studies that have answered the same question; as well as provides a method for managing large quantities of data. It has a clear criteria for retrieval/appraisal/synthesis of evidence from individual RCTs as well as other well-controlled trials. A recent study demonstrated that there were 49 systematic review and meta-analysis in the field of endodontics worldwide [3]. Our results, however, revealed that only 2 systematic reviews (~4%) originated from Iran. RCTs are regarded as the best study designs to test the efficacy of medical/dental treatments. In RCT the subjects are assigned by chance to separate groups that evaluate new and standard treatments; neither the operators nor the patients can choose which group. At the time of the trial, it is not known which treatment protocol is worse/best. The number of RCTs in the field of dentistry or endodontics has not been reported; however it is estimated that ~4-6% of published articles classified as RCT. Our results showed that RCTs from Iran are ~8% of PubMed-indexed published endodontic articles which seems at or even above the global level. The aim of our study was to assess the quantity of high-level evidences in endodontics; therefore, we did not appraise the quality of 25 RCTs. It was reported that the quality of RCT in the field of dentistry is still poor, and more efforts for progress are needed. The trials that are not well designed provide biased estimates of the treatment effects; moreover a journal’s impact factor (IF) is not related to the quality of results [35]. Within the outline of EBD, dentists should conscientiously, explicitly, and judiciously use the best current evidence in making decisions about the care of individual patients. Therefore, before trusting RCT reports, a careful evaluationof the reported trial is needed. Randomization as well as blinding, allocation concealment, drop outs analysis are critical quality apparatus of RCTs [35]. Vital pulp therapy (VPT) as well as anesthesia and pain were two main subjects of published Iranian RCTs. VPT in pediatric dentistry is a well established treatment modality. Our data showed that 7 VPT/RCTs were carried out in the field of pediatric to test Formocresol, MTA, Electrosurgery, calcium hydroxide and CEM cement as pulpotomy agents [16][20][23][27][31]. However VPT for mature permanent teeth with sign/symptom of irreversible pulpitis and also carious pulp exposure remains the most challenging areas in endodontics. Our results revealed that 8 VPT/RCTs were carried out for permanent teeth in the field of endodontics to test MTA and CEM cement as pulp capping or pulpotomy biomaterials [11][12][13][14][15][17][18][22]. These RCTs provide a body of evidence that permanent teeth with irreversible pulpitis can be managed successfully by VPT. A recent systematic review confirms this new concept [36]. It was reported that Mashad, Tabriz and Tehran dental schools were the top three institutions when looking at the number of published PubMed-indexed endodontic articles in Iran [4]; however, the present results revealed that Shahid Beheshti, Kerman and Mashad dental schools provide the majority (>55%) of high-level evidences in the field of endodontics. Relevant literature regarding patents scientometrics in endodontics was found not. However, we found 4 patent documents in the field of endodontics originated from Iran in WIPO and USPTO. There are no patents from other dental subspecialties from Iran.

Conclusion

It seems that endodontics rank at the first place for science production as well as technology in Iran.
  32 in total

1.  Evidence-based dentistry: Part IV. Research design and levels of evidence.

Authors:  S E Sutherland
Journal:  J Can Dent Assoc       Date:  2001 Jul-Aug       Impact factor: 1.316

2.  Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.

Authors:  Ali Nosrat; Amir Seifi; Saeed Asgary
Journal:  Int J Paediatr Dent       Date:  2012-02-06       Impact factor: 3.455

3.  The efficacy comparison of ibuprofen, acetaminophen-codeine, and placebo premedication therapy on the depth of anesthesia during treatment of inflamed teeth.

Authors:  Jalil Modaresi; Omid Dianat; Mohammad Ali Mozayeni
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-06-27

4.  One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial.

Authors:  Saeed Asgary; Mohammad Jafar Eghbal; Jamileh Ghoddusi; Shahram Yazdani
Journal:  Clin Oral Investig       Date:  2012-03-21       Impact factor: 3.573

5.  Efficacy of combining a buccal infiltration with an inferior alveolar nerve block for mandibular molars with irreversible pulpitis.

Authors:  Masoud Parirokh; Seyed Amir Satvati; Rohollah Sharifi; Ali Reza Rekabi; Hedayat Gorjestani; Nozar Nakhaee; Paul V Abbott
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03

6.  The effect of pulpotomy using a calcium-enriched mixture cement versus one-visit root canal therapy on postoperative pain relief in irreversible pulpitis: a randomized clinical trial.

Authors:  Saeed Asgary; Mohammad Jafar Eghbal
Journal:  Odontology       Date:  2010-07-23       Impact factor: 2.634

7.  Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial.

Authors:  Saeed Asgary; Mohammad Jafar Eghbal
Journal:  Acta Odontol Scand       Date:  2012-02-20       Impact factor: 2.331

8.  Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.

Authors:  H Noorollahian
Journal:  Br Dent J       Date:  2008-04-18       Impact factor: 1.626

9.  Evaluation of the effect of locally administered amitriptyline gel as adjunct to local anesthetics in irreversible pulpitis pain.

Authors:  A A Moghadamnia; M Partovi; I Mohammadianfar; Z Madani; E Zabihi; M R Hamidi; M Baradaran
Journal:  Indian J Dent Res       Date:  2009 Jan-Mar

10.  A Scientometric Study of PubMed-Indexed Endodontic Articles: A Comparison between Iran and Other Regional Countries.

Authors:  Mohammad Jafar Eghbal; Negar Davari Ardakani; Saeed Asgary
Journal:  Iran Endod J       Date:  2012-06-01
View more
  2 in total

1.  The level of evidence in two leading endodontic journals.

Authors:  Leila Shafiei; Arash Shahravan
Journal:  Iran Endod J       Date:  2013-01-20

Review 2.  Various strategies for pain-free root canal treatment.

Authors:  Masoud Parirokh; Paul V Abbott
Journal:  Iran Endod J       Date:  2013-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.